ArticleCardiovascular diabetology2023

Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program.

Ildiko Lingvay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.